vs
Bandwidth Inc.（BAND）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Bandwidth Inc.的季度营收约是再鼎医药的1.6倍（$208.8M vs $127.1M），Bandwidth Inc.同比增速更快（20.1% vs 17.1%），Bandwidth Inc.自由现金流更多（$-1.0M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 9.7%）
Bandwidth Inc.是一家通信平台即服务提供商，依托自有全球IP语音网络，为客户提供语音、短信及应急服务相关的软件API产品，帮助开发者便捷集成通信功能，全球客户可借助其方案快速搭建符合需求的通信服务体系。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
BAND vs ZLAB — 直观对比
营收规模更大
BAND
是对方的1.6倍
$127.1M
营收增速更快
BAND
高出3.0%
17.1%
自由现金流更多
BAND
多$25.7M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
9.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $208.8M | $127.1M |
| 净利润 | $4.0M | — |
| 毛利率 | 37.3% | 51.0% |
| 营业利润率 | 60.5% | -54.6% |
| 净利率 | 1.9% | — |
| 营收同比 | 20.1% | 17.1% |
| 净利润同比 | 200.0% | — |
| 每股收益（稀释后） | $-0.08 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BANDZLAB
| Q1 26 | $208.8M | — | ||
| Q4 25 | $207.7M | $127.1M | ||
| Q3 25 | $191.9M | $115.4M | ||
| Q2 25 | $180.0M | $109.1M | ||
| Q1 25 | $174.2M | $105.7M | ||
| Q4 24 | $210.0M | $108.5M | ||
| Q3 24 | $193.9M | $101.8M | ||
| Q2 24 | $173.6M | $100.1M |
净利润BANDZLAB
| Q1 26 | $4.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | $-36.0M | ||
| Q2 25 | $-4.9M | $-40.7M | ||
| Q1 25 | $-3.7M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $413.0K | $-41.7M | ||
| Q2 24 | $4.1M | $-80.3M |
毛利率BANDZLAB
| Q1 26 | 37.3% | — | ||
| Q4 25 | 37.6% | 51.0% | ||
| Q3 25 | 38.5% | 59.5% | ||
| Q2 25 | 39.8% | 60.6% | ||
| Q1 25 | 41.0% | 63.6% | ||
| Q4 24 | 36.4% | 61.5% | ||
| Q3 24 | 37.7% | 64.1% | ||
| Q2 24 | 37.3% | 64.9% |
营业利润率BANDZLAB
| Q1 26 | 60.5% | — | ||
| Q4 25 | -1.9% | -54.6% | ||
| Q3 25 | -1.0% | -42.3% | ||
| Q2 25 | -2.1% | -50.3% | ||
| Q1 25 | -2.7% | -53.3% | ||
| Q4 24 | -1.3% | -62.6% | ||
| Q3 24 | -0.5% | -66.6% | ||
| Q2 24 | -3.5% | -76.0% |
净利率BANDZLAB
| Q1 26 | 1.9% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -0.6% | -31.2% | ||
| Q2 25 | -2.7% | -37.3% | ||
| Q1 25 | -2.1% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.2% | -40.9% | ||
| Q2 24 | 2.3% | -80.2% |
每股收益（稀释后）BANDZLAB
| Q1 26 | $-0.08 | — | ||
| Q4 25 | $-0.10 | $-0.05 | ||
| Q3 25 | $-0.04 | $-0.03 | ||
| Q2 25 | $-0.16 | $-0.04 | ||
| Q1 25 | $-0.13 | $-0.04 | ||
| Q4 24 | $0.27 | $-0.09 | ||
| Q3 24 | $0.01 | $-0.04 | ||
| Q2 24 | $-0.17 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $47.3M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $405.7M | $715.5M |
| 总资产 | $984.2M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BANDZLAB
| Q1 26 | $47.3M | — | ||
| Q4 25 | $111.3M | $689.6M | ||
| Q3 25 | $80.4M | $717.2M | ||
| Q2 25 | $68.1M | $732.2M | ||
| Q1 25 | $41.7M | $757.3M | ||
| Q4 24 | $83.8M | $779.7M | ||
| Q3 24 | $79.9M | $616.1M | ||
| Q2 24 | $76.4M | $630.0M |
股东权益BANDZLAB
| Q1 26 | $405.7M | — | ||
| Q4 25 | $400.0M | $715.5M | ||
| Q3 25 | $392.7M | $759.9M | ||
| Q2 25 | $384.5M | $791.7M | ||
| Q1 25 | $345.4M | $810.8M | ||
| Q4 24 | $312.5M | $840.9M | ||
| Q3 24 | $336.6M | $667.7M | ||
| Q2 24 | $307.4M | $704.2M |
总资产BANDZLAB
| Q1 26 | $984.2M | — | ||
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $964.4M | $1.2B | ||
| Q4 24 | $989.2M | $1.2B | ||
| Q3 24 | $1.0B | $985.3M | ||
| Q2 24 | $1.0B | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | $-26.7M |
| 自由现金流率自由现金流/营收 | -0.5% | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流BANDZLAB
| Q1 26 | — | — | ||
| Q4 25 | $38.6M | $-26.0M | ||
| Q3 25 | $22.2M | $-32.0M | ||
| Q2 25 | $31.7M | $-31.0M | ||
| Q1 25 | $-3.1M | $-61.7M | ||
| Q4 24 | $36.5M | $-55.8M | ||
| Q3 24 | $20.5M | $-26.8M | ||
| Q2 24 | $24.4M | $-42.2M |
自由现金流BANDZLAB
| Q1 26 | $-1.0M | — | ||
| Q4 25 | — | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | — | $-28.2M | ||
| Q2 24 | — | $-42.9M |
自由现金流率BANDZLAB
| Q1 26 | -0.5% | — | ||
| Q4 25 | — | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% |
资本支出强度BANDZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.7% |
现金转化率BANDZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 49.55× | — | ||
| Q2 24 | 6.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BAND
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
